[1]
Osuch, D. et al. 2024. Use of Glucagon-like peptide 2 (GLP-2) analogs in inflammatory bowel disease. Quality in Sport. 17, (Aug. 2024), 53227. DOI:https://doi.org/10.12775/QS.2024.17.53227.